Ulrich Sachs: A New Strategy to Prevent Platelet Transfusion Refractoriness
Ulrich Sachs, Chief Physician at University Hospital Giessen and Marburg, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The Journal of Immunology, adding:
“I am delighted that we are part of this fruitful cooperation with the team of Alan Lazarus in Toronto, Canada.
A monovalent single-chain variable fragment antibody that targets the human Fc gamma receptor IIIA prevents destructive platelet phagocytosis in a humanized mouse model of platelet transfusion refractoriness.
That‘s excellent news! And it offers hope of a simple solution to a major everyday problem in transfusion medicine: providing platelet transfusions to patients with antibodies against HLA.”
Title: FcγRIII blockade prevents anti-HLA–mediated platelet clearance in a humanized murine model of platelet transfusion refractoriness
Authors: Lazaro Gil Gonzalez, Kevin Doyoon Won, Zoya Tawhidi, Alequis Pavon Oro, Yaima Tundidor Cabado, Yoelys Cruz-Leal, Akash Gupta, Hanna Wabnitz, Ulrich J. Sachs, Rick Kapur, Alan H. Lazarus
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC